Please login to the form below

Not currently logged in
Email:
Password:

ACM Global Central Laboratory appoints Timo Jackle

He joins from Bausch & Lomb

ACM_Timo_JackleTimo Jackle has joined US-based firm ACM Global Central Laboratory as vice president of clinical trials operations.

Jackle moves to the company from Bausch & Lomb, where he served most recently as executive director of global clinical trials operations, overseeing multinational pharmaceutical and medical device studies.

Angela Panzarella, president of ACM, said: “Timo is a highly collaborative leader with extensive experience in clinical trials research, quality assurance, global operations, and business process improvement.

“His strong focus on customer service and lengthy track record in improving business processes will no doubt be an asset to our clients.”

At ACM, Jackle joins the company's executive management team and in his new role he will be responsible for overseeing project management, data management, study support, specimen management, and logistics activities for all of ACM Global's US-based clinical trials.

He will also be tasked with developing and implementing its strategy for operations globally.

2nd May 2013

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics